What is the current price and exchange for TLIK.DE stock?

TLIK.DE stock trades on XETRA in Germany at **€0.61** pre-market on 21 Feb 2026. Volume is low at **375** shares so prices can move quickly on limited orders.

What are Meyka AI's ratings and forecast for TLIK.DE stock?

Meyka AI rates TLIK.DE at **65.94/100** (Grade B, HOLD). The model projects a near-term target of **€0.70** (+14.75%) and a 12-month scenario of **€0.95** (+55.74%). Forecasts are projections, not guarantees.

What are the main risks for TLIK.DE stock investors?

Main risks include negative EPS (**-0.13**), thin liquidity (avg volume **704**), a small market cap (**€3,802,386.00**), and potential dilution. These factors raise volatility and execution risk.

How should traders approach an oversold bounce in TLIK.DE stock?

Traders should size small, use a stop under recent support (for example **€0.55**), and require a volume pick-up above the average before adding. Target the 200-day average (**€0.64**) or **€0.70** to lock gains.

DE Stocks

TLIK.DE Arzneiwerk AG XETRA pre-market: €0.61 oversold bounce to €0.70

ByDanny Kontos February 21, 2026February 21, 2026

TLIK.DE stock is trading pre-market on XETRA at €0.61 on 21 Feb 2026, showing a short-term recovery after heavy selling. The share is up 4.27% versus the prior close with volume 375 as traders eye a mean-reversion trade. We frame this as an oversold bounce opportunity for Arzneiwerk AG VIDA (TLIK.DE) in Germany, driven by a shallow base near the 50-day average and stretched sentiment in the Technology sector.